Thrombectomy Devices Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | Stryker Corporation, Medtronic plc, Boston Scientific Corporation, Johnson and Johnson, Terumo Corporation, Penumbra Inc., Edwards Lifesciences Corporati

As per the report, the thrombectomy devices market size has grown strongly in recent years. It will grow from $1.46 billion in 2023 to $1.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.1 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10752&type=smp

Surge In Cardiovascular Diseases Drives The Growth Of The Thrombectomy Devices Market
An increase in the incidence of cardiovascular diseases is expected to propel the growth of the thrombectomy devices market going forward. Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels, including coronary artery disease, heart failure, and arrhythmias. Thrombectomy is a procedure used to remove blood clots that have formed within blood vessels, including those in cardiovascular diseases such as acute ischemic stroke and acute myocardial infarction (heart attack); as a result, an increase in the incidence of cardiovascular diseases increases the demand for thrombectomy devices. For instance, in January 2023, according to a report shared by the American Heart Association, a US-based non-profit organization that supports cardiovascular medical research, 928,741 people died in the United States in 2020 as a result of cardiovascular disease (CVD), which was reported as the primary cause of death. Worldwide mortality from CVD was estimated at 19.05 million in 2020. Therefore, an increase in the incidence of cardiovascular disease devices is driving the growth of the thrombectomy devices market.

The Rise Of Technological Innovations In Thrombectomy Devices Market
Technological advancements are a key trend gaining popularity in the thrombectomy devices market. Companies operating in the thrombectomy devices market are adopting new technologies to sustain their position in the market. For instance, in February 2022, CERENOVUS, a US-based company engaged in neurovascular care and part of Johnson & Johnson Medical Devices Companies, launched EMBOGUARD, a next-generation balloon guide catheter. This is used in endovascular procedures, including those for patients with acute ischemic stroke. EMBOGUARD is the latest addition to join CERENOVUS Stroke Solutions, a suite of technologies designed with compatibility in mind to assist physicians in performing mechanical thrombectomy procedures. The EMBOGUARDTM Balloon Guide Catheter is intended to improve clot clearance by regulating blood flow locally during MT operations. Balloon guide catheters improve first-pass recanalization, shorten the surgery, and lower the likelihood of clot fragments breaking off and generating distant emboli.

The thrombectomy devices market covered in this report is segmented -

1) By Product Type: Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Other Product Types
2) By Application: Cardiovascular Application, Peripheral Application, Neurovascular Application
3) By End-User: Hospitals, Surgical centers, Ambulatory, Academia, Contract Research Organizations(CROs)

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10752&type=discount

Major companies operating in the thrombectomy devices market report are Stryker Corporation, Medtronic plc, Boston Scientific Corporation, Johnson and Johnson, Terumo Corporation, Penumbra Inc., Edwards Lifesciences Corporation, Argon Medical Devices Inc., Teleflex Incorporated, AngioDynamics, Koninklijke Philips NV, Spectranetics Corporation, Abbott Laboratories, Inari Medical Inc., C. R. Bard Inc., BTG International Ltd., Walk Vascular LLC, Phenox GmbH, Acandis GmbH & Co. KG, Straub Medical AG, MicroVention Inc., Vascular Solutions Inc., Rapid Medical, Endo International plc, Acrostak AG, Neuravi Limited, Control Medical Technology LLC, Kaneka Corporation, Arteria Therapeutics Inc., Baxter International

Contents of the report:
1. Executive Summary
2. Thrombectomy Devices Market Report Structure
3. Thrombectomy Devices Market Trends And Strategies
4. Thrombectomy Devices Market - Macro Economic Scenario
5. Thrombectomy Devices Market Size And Growth
…..
27. Thrombectomy Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/thrombectomy-devices-global-market-report

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.